BioSpace News Archive

Axonics, Inc., a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, announced that it has commenced a proposed public offering of $150,000,000 in shares of its common stock.

Labcorp, a leading global life sciences company, is working with the U.S. Department of Health and Human Services to raise awareness of potentially lifesaving monoclonal antibody COVID-19 therapies.

Jaguar Health, Inc. today announced that Company management will host a webcast on Monday, May 17, 2021 at 8:30 a.m. Eastern Time to review first-quarter 2021 financials and provide business updates.

Heligenics, Inc. today announced a new collaboration with The Jackson Laboratory (JAX).

CytoSorbents Corporation (NASDAQ: CTSO), a critical care leader commercializing its CytoSorb ® and other blood purification technologies to treat deadly conditions in critically-ill and cardiac surgery patients around the world, announced the U.S Army Medical Research and Development Command has awarded CytoSorbents a contract

Bioheuris, an agbiotech startup using synthetic biology and gene editing to fight weeds, and Gensus, the Argentine company that produces and markets certified cotton seeds, today announced a partnership to develop herbicide resistance in this crop using CRISPR gene editing.

Harvard T.H. Chan School of Public Health today announced that Kizzmekia S. Corbett will join the School as an assistant professor in the Department of Immunology and Infectious Diseases

Allied BioScience, maker of revolutionary residual antiviral surface coating SurfaceWise2™, announced that Midwestern private equity firm Capital7, LLC has made an early stage investment in its Series C Preferred Stock.

Devonian Health Group Inc., a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical products announced that they will be participating in Renmark Financial Communications Inc.’s live Virtual Non-Deal Roadshow Series to discuss its latest investor presentation on Thursday, May 13 at 10:00 AM EDT.

Applied DNA Sciences, Inc., a leader in Polymerase Chain Reaction -based DNA manufacturing, announced that its Applied DNA Clinical Labs, LLC subsidiary received CLIA certification from the New York State Department of Health Clinical Laboratory Evaluation Program for COVID-19 testing using EUA-authorized methods and devices.